Contingency Fee Litigation Retention Agreements
Below are all active contingency fee litigation retention agreements that the Attorney General has executed, except matters in which disclosure is currently under review by a court. The Attorney General often retains private counsel for matters that require specialized expertise or involve an extensive commitment of financial resources and personnel. By retaining private counsel, the Attorney General is able to pursue effective enforcement of state statutes in large, important cases that the Attorney General’s Office itself would otherwise be unable to pursue.
- Affinion/Trilegiant (marketing and billing) – litigation retention agreement
- AstraZeneca (Seroquel) – litigation retention agreement
- Cephalon (Provigil, Gabitril, Actiq) – litigation retention agreement
- GSK (Avandia) – litigation retention agreement
- Janssen (Risperdal) – litigation retention agreement
- Janssen (Risperdal) – appellate litigation retention agreement
- McKesson (Average Wholesale Price) – litigation retention agreement
- Merck (Vioxx) – litigation retention agreement
- Multiple pharmaceutical companies (Average Wholesale Price) – litigation retention agreement
- Multiple technology companies (liquid crystal displays) – litigation retention agreement
- Multiple oil companies (underground storage tanks) – litigation retention agreement
Columbia, SC